Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer-Reference-Cited by-同舟云学术

Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer

Published:2020-12-09 Issue:4 Volume:42 Page:402-409
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Cheng Bernard,Sethi Ila,Davisson Neena,Brandon David,Barron Bruce,Galt James,Bercu Zachary,Schuster David M.,Kokabi Nima

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: a large single-center experience in 81 patients.;Fendler;J Nucl Med,2016

2. Incidence and prognostic factors of patients with synchronous liver metastases upon initial diagnosis of breast cancer: a population-based study.;Zhao;Cancer Manag Res,2018

3. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.;Marty;J Clin Oncol,2005

4. Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases-A single-center experience.;Pieper;J Vasc Interv Radiol,2016

5. Prognostic factors in 1,038 women with metastatic breast cancer.;Largillier;Ann Oncol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies;CardioVascular and Interventional Radiology;2024-02-06

2. Locoregional Therapies for Primary and Metastatic Breast Cancer: AJR Expert Panel Narrative Review;American Journal of Roentgenology;2023-06-28

3. Radioembolisation of liver metastases;Journal of Medical Imaging and Radiation Oncology;2023-06-21

4. Dosimetric impact of 3D motion-compensated SPECT reconstruction for SIRT planning;EJNMMI Physics;2023-02-07

5. Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90);CardioVascular and Interventional Radiology;2022-08-25